Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Udenafil in PAH
NCT02304198Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of udenafil in pulmonary arterial hypertension (PAH), sponsored by Dong-A ST. Started Apr 2014; status: completed.
02
Drugs
udenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02304198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304198.